Clinical Trials Browser

Phase 3 × Has results × Squamous Cell Non-small Cell Lung Cancer × Clear all

NCT01642004 2022-12-28

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)

Phase 3 Completed

272 enrolled 23 charts

Squamous Cell Non-small Cell Lung Cancer